Development and internal validation of multivariable prediction models for biochemical failure after MRI-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer | Zendy

T. Willigenburg | Zendy; Marieke van Son | Zendy; Sandrine M.G. van de Pol | Zendy; Wietse S.C. Eppinga | Zendy; J J W Lagendijk | Zendy; Hans C.J. de Boer | Zendy; Marinus A. Moerland | Zendy; Jochem R.N. van der Voort van Zyp | Zendy; Max Peters | Zendy

Open Access

Development and internal validation of multivariable prediction models for biochemical failure after MRI-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer

Author(s) -

T. Willigenburg,

Marieke van Son,

Sandrine M.G. van de Pol,

Wietse S.C. Eppinga,

J J W Lagendijk,

Hans C.J. de Boer,

Marinus A. Moerland,

Jochem R.N. van der Voort van Zyp,

Max Peters

Publication year - 2021

Publication title -

clinical and translational radiation oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.336

H-Index - 15

ISSN - 2405-6308

DOI - 10.1016/j.ctro.2021.06.005

Subject(s) - brachytherapy , medicine , nomogram , prostate cancer , salvage therapy , proportional hazards model , prostatectomy , urology , nuclear medicine , radiation therapy , oncology , surgery , cancer , chemotherapy

Magnetic resonance-guided focal salvage high-dose-rate brachytherapy (FS-HDR-BT) for radiorecurrent prostate cancer (PCa) shows low toxicity rates. However, biochemical failure (BF) after treatment occurs frequently. We developed two prediction models for BF (Phoenix definition) with the aim of enhancing patient counselling before FS-HDR-BT and during follow-up.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research